Residual platelet activity in patients managed with clopidogrel: Clinical implications for the management of patients with acute coronary syndrome

Residual platelet activity in patients managed with clopidogrel: Clinical implications for the management of patients with acute coronary syndrome

Bibliographic Details
Main Author:	João Morais
Format:	Article
Language:	English
Published:	Elsevier 2012-09-01
Series:	Revista Portuguesa de Cardiologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2174204912001316

Similar Items

Clopidogrel resistance in patients with acute coronary syndrome
by: N S Frolova, et al.
Published: (2010-08-01)

Pharmacodynamics and clinical effectiveness of clopidogrel and atorvastin in patients with acute coronary syndrome and hyperlipidaemia
by: A. S. Sivkov, et al.
Published: (2009-08-01)

Assessing the efficacy of aspirin and clopidogrel in patients with acute coronary syndromes
by: Varadharajan, Vatchsala Sree
Published: (2018)

High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel.
by: Tobias Geisler, et al.
Published: (2015-01-01)

Clopidogrel responsiveness in chronic kidney disease patients with acute coronary syndrome
by: Hale Ünal Aksu, et al.
Published: (2014-03-01)

Thromboelastography evaluation of low response to clopidogrel in patients with acute coronary syndrome
by: Lijia Zhao, et al.
Published: (2018-03-01)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Nicholas B Norgard, et al.
Published: (2009-10-01)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
by: Grima DT, et al.
Published: (2014-01-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01)

Determinants to optimize response to clopidogrel in acute coronary syndrome
by: Betti Giusti, et al.
Published: (2010-04-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

Inflammatory and Antioxidant Pattern Unbalance in “Clopidogrel-Resistant” Patients during Acute Coronary Syndrome
by: Raffaele Caruso, et al.
Published: (2015-01-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

Platelet Count in Patients with Acute Coronary Syndrome
by: Hasan Barzegari, et al.
Published: (2018-02-01)

Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention
by: Kwan T, et al.
Published: (2011-06-01)

CYP2C19*2 and Other Allelic Variants Affecting Platelet Response to Clopidogrel Tested by Thrombelastography in Patients with Acute Coronary Syndrome
by: Jian Liu, et al.
Published: (2015-01-01)

Clopidogrel therapy effects on cell hemostasis in acute coronary syndrome
by: R. A. Rakhimova, et al.
Published: (2008-12-01)

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
by: Parag Admane, et al.
Published: (2013-03-01)

Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients
by: Fei-Yan Xiao, et al.
Published: (2017-08-01)

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in Chinese elderly patients with acute coronary syndrome
by: Wang HD, et al.
Published: (2016-07-01)

NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: K. B. Mirzaev, et al.
Published: (2018-03-01)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
by: Wiktor Kuliczkowski, et al.
Published: (2021-01-01)

The expression profile of platelet‐derived miRNA in coronary artery disease patients with clopidogrel resistance
by: Shaoyi Lin, et al.
Published: (2021-04-01)

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?
by: Matthew A Silva, et al.
Published: (2006-03-01)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
by: Aguiar, M.O, et al.
Published: (2022)

Effect of atorvastatin and clopidogrel on inflammatory factors, blood coagulation and platelet activation in patients with acute cerebral infarction
by: Shuang Li, et al.
Published: (2018-07-01)

Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy
by: Sehun Kim, et al.
Published: (2021-03-01)

Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome
by: Wenxing Peng, et al.
Published: (2019-01-01)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
by: Ying Yao, et al.
Published: (2019-10-01)

Use of clopidogrel generics in patients with acute coronary syndrome: have all issues have been resolved?
by: AN Yakovlev
Published: (2014-12-01)

Platelet and white blood cell functional activity in patients with acute coronary syndrome
by: N. A. Kosheleva, et al.
Published: (2004-12-01)

Mean platelet volume in acute coronary syndrome: Diagnostic implications
by: Gaveshna Gargi, et al.
Published: (2018-01-01)

Budget impact analysis of antiplatelet therapy with ticagrelor and clopidogrel in patients with acute coronary syndrome after coronary artery bypass surgery
by: S K Zyryanov, et al.
Published: (2016-09-01)

Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
by: Fan ZG, et al.
Published: (2019-02-01)

Factors influencing platelet aggregation in patients with acute coronary syndrome
by: A V Mazurov, et al.
Published: (2014-09-01)

The utility of inflammation and platelet biomarkers in patients with acute coronary syndromes
by: Joanna Kamińska, et al.
Published: (2018-11-01)

Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017
by: Safoura Sheikh Rezaei, et al.
Published: (2020-10-01)

P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Po-Wei Chen, et al.
Published: (2020-06-01)

Relationship between human platelet antigen-1 gene polymorphism and clopidogrel resistance in patients with coronary artery disease
by: İbrahim Halil Tanboğa, et al.
Published: (2013-07-01)

Evaluation of Endothelial and Platelet Derived Microparticles in Patients with Acute Coronary Syndrome
by: Melvin George, et al.
Published: (2015-12-01)